CARsgen Therapeutics (HKG:2171) said YIJIE Biotech and parties acting in concert with it acquired 100,000 additional shares in the firm between Nov. 6 and Nov. 10, a Thursday Hong Kong bourse filing said.
Shares of the biopharmaceutical company were up nearly 2% in Friday afternoon trading.
Substantial shareholder YIJIE Biotech and its concert parties now hold 218 million, or 37.92%, shares in the firm.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments